ZSAMAE LOPEZ: Open Payments
NPI 1194186304 · BERGENFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 28 payments from 13 companies in 2025. Trend: 2023 $434 · 2024 $122 · 2025 $608
Food & beverage: $476Education: $132
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $114 |
| Janssen Biotech, Inc. | 5 | $92 |
| Merck Sharp & Dohme LLC | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| Genentech USA, Inc. | 3 | $44 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Novo Nordisk Inc | 1 | $32 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $25 |
Products named: DARZALEX, ENHERTU, OJJAARA, KISQALI, Ozempic, KEYTRUDA, Tecentriq, Nubeqa.
Industry payments across NJ — which companies pay providers there.
